![Food and Drug Administration / Pharmacology / Pharmaceutical industry / Pharmaceuticals policy / FDA Fast Track Development Program / Approved drug / Amyotrophic lateral sclerosis / Orphan drug / Riluzole / Pharmaceutical sciences / Health / Clinical research Food and Drug Administration / Pharmacology / Pharmaceutical industry / Pharmaceuticals policy / FDA Fast Track Development Program / Approved drug / Amyotrophic lateral sclerosis / Orphan drug / Riluzole / Pharmaceutical sciences / Health / Clinical research](/pdf-icon.png)
| Document Date: 2015-01-15 13:15:12 Open Document File Size: 123,29 KBShare Result on Facebook
Company Genervon Biopharmaceuticals LLS / / Event FDA Phase / / MedicalCondition terrible disease / ALS / Lou Gehrig’s Disease / disease / amyotrophic lateral sclerosis / / Organization FDA / / Person Lou Gehrig / / Position Senatorial Official / / Product Riluzole / GMC6 / GM6 / /
SocialTag |